MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

L. De Mattos-Arruda; G. Bottai; P.G. Nuciforo; L. Di Tommaso; E. Giovannetti; V. Peg; A. Losurdo; J. Perez-Garcia; G. Masci; F. Corsi; J. Cortes; J. Seoane; G.A. Calin; L. Santarpia

doi:10.18632/oncotarget.5495

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

L. De Mattos-Arruda, G. Bottai, P.G. Nuciforo, L. Di Tommaso, E. Giovannetti, V. Peg, A. Losurdo, J. Perez-Garcia, G. Masci, F. Corsi, J. Cortes, J. Seoane, G.A. Calin, L. Santarpia

Medical oncology laboratory

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	37269-37280
Journal	Oncotarget
Volume	6
Issue number	35
DOIs	https://doi.org/10.18632/oncotarget.5495
Publication status	Published - 2015

Cite this

De Mattos-Arruda, L., Bottai, G., Nuciforo, P. G., Di Tommaso, L., Giovannetti, E., Peg, V., ... Santarpia, L. (2015). MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget, 6(35), 37269-37280. https://doi.org/10.18632/oncotarget.5495

De Mattos-Arruda, L. ; Bottai, G. ; Nuciforo, P.G. ; Di Tommaso, L. ; Giovannetti, E. ; Peg, V. ; Losurdo, A. ; Perez-Garcia, J. ; Masci, G. ; Corsi, F. ; Cortes, J. ; Seoane, J. ; Calin, G.A. ; Santarpia, L. / MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. In: Oncotarget. 2015 ; Vol. 6, No. 35. pp. 37269-37280.

@article{a7b30167460345e2ba4b9eb248e47f79,

title = "MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients",

author = "{De Mattos-Arruda}, L. and G. Bottai and P.G. Nuciforo and {Di Tommaso}, L. and E. Giovannetti and V. Peg and A. Losurdo and J. Perez-Garcia and G. Masci and F. Corsi and J. Cortes and J. Seoane and G.A. Calin and L. Santarpia",

year = "2015",

doi = "10.18632/oncotarget.5495",

language = "Undefined/Unknown",

volume = "6",

pages = "37269--37280",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "35",

}

De Mattos-Arruda, L, Bottai, G, Nuciforo, PG, Di Tommaso, L, Giovannetti, E, Peg, V, Losurdo, A, Perez-Garcia, J, Masci, G, Corsi, F, Cortes, J, Seoane, J, Calin, GA & Santarpia, L 2015, 'MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients', Oncotarget, vol. 6, no. 35, pp. 37269-37280. https://doi.org/10.18632/oncotarget.5495

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. / De Mattos-Arruda, L.; Bottai, G.; Nuciforo, P.G.; Di Tommaso, L.; Giovannetti, E.; Peg, V.; Losurdo, A.; Perez-Garcia, J.; Masci, G.; Corsi, F.; Cortes, J.; Seoane, J.; Calin, G.A.; Santarpia, L.

In: Oncotarget, Vol. 6, No. 35, 2015, p. 37269-37280.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

AU - De Mattos-Arruda, L.

AU - Bottai, G.

AU - Nuciforo, P.G.

AU - Di Tommaso, L.

AU - Giovannetti, E.

AU - Peg, V.

AU - Losurdo, A.

AU - Perez-Garcia, J.

AU - Masci, G.

AU - Corsi, F.

AU - Cortes, J.

AU - Seoane, J.

AU - Calin, G.A.

AU - Santarpia, L.

PY - 2015

Y1 - 2015

U2 - 10.18632/oncotarget.5495

DO - 10.18632/oncotarget.5495

M3 - Article

C2 - 26452030

VL - 6

SP - 37269

EP - 37280

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 35

ER -

Access to Document

10.18632/oncotarget.5495